Macquarie Group LTD Neurocrine Biosciences Inc Transaction History

Macquarie Group LTD

  • $83.5 Billion
  • Q3 2025

A detailed history of Macquarie Group LTD transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Macquarie Group LTD holds 315,462 shares of NBIX stock, worth $45.7 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
315,462
Previous 270,502 16.62%
Holding current value
$45.7 Million
Previous $34 Million 30.25%
% of portfolio
0.05%
Previous 0.04%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
BUY
$123.98 - $146.67 $5.57 Million - $6.59 Million
44,960 Added 16.62%
315,462 $44.3 Million
Q2 2025

Aug 14, 2025
BUY
$87.54 - $128.18 $3.43 Million - $5.02 Million
39,154 Added 16.92%
270,502 $34 Million
Q1 2025

May 15, 2025
SELL
$107.22 - $153.29 $4.59 Million - $6.56 Million
-42,778 Reduced 15.61%
231,348 $25.6 Million
Q4 2024

Feb 14, 2025
SELL
$111.62 - $139.44 $24.3 Million - $30.4 Million
-218,064 Reduced 44.3%
274,126 $37.4 Million
Q3 2024

Nov 14, 2024
BUY
$114.58 - $153.15 $25.3 Million - $33.9 Million
221,213 Added 81.64%
492,190 $56.7 Million
Q2 2024

Aug 09, 2024
SELL
$130.86 - $143.19 $658,618 - $720,675
-5,033 Reduced 1.82%
270,977 $37.3 Million
Q1 2024

May 14, 2024
SELL
$130.4 - $143.74 $6.8 Million - $7.49 Million
-52,119 Reduced 15.88%
276,010 $38.1 Million
Q4 2023

Feb 14, 2024
BUY
$106.07 - $132.76 $7.37 Million - $9.23 Million
69,518 Added 26.88%
328,129 $43.2 Million
Q3 2023

Nov 14, 2023
SELL
$94.02 - $117.1 $76,720 - $95,553
-816 Reduced 0.31%
258,611 $29.1 Million
Q2 2023

Aug 14, 2023
SELL
$89.53 - $104.87 $2.97 Million - $3.48 Million
-33,183 Reduced 11.34%
259,427 $24.5 Million
Q1 2023

May 15, 2023
BUY
$94.11 - $123.02 $686,626 - $897,553
7,296 Added 2.56%
292,610 $29.6 Million
Q4 2022

Feb 21, 2023
SELL
$106.72 - $127.06 $105,652 - $125,789
-990 Reduced 0.35%
285,314 $34.1 Million
Q3 2022

Nov 14, 2022
SELL
$92.03 - $107.81 $606,109 - $710,036
-6,586 Reduced 2.25%
286,304 $30.4 Million
Q2 2022

Aug 15, 2022
SELL
$75.79 - $100.07 $1.91 Million - $2.52 Million
-25,173 Reduced 7.91%
292,890 $28.6 Million
Q1 2022

May 16, 2022
BUY
$72.45 - $94.81 $4.73 Million - $6.19 Million
65,302 Added 25.84%
318,063 $29.8 Million
Q4 2021

Feb 11, 2022
BUY
$79.65 - $106.22 $1.49 Million - $1.98 Million
18,676 Added 7.98%
252,761 $21.5 Million
Q3 2021

Nov 12, 2021
SELL
$86.18 - $99.03 $204,332 - $234,800
-2,371 Reduced 1.0%
234,085 $22.5 Million
Q2 2021

Aug 13, 2021
BUY
$89.43 - $102.27 $688,521 - $787,376
7,699 Added 3.37%
236,456 $23 Million
Q1 2021

May 14, 2021
SELL
$87.57 - $119.4 $243,707 - $332,290
-2,783 Reduced 1.2%
228,757 $22.2 Million
Q4 2020

Feb 16, 2021
SELL
$86.91 - $108.33 $62.5 Million - $77.8 Million
-718,601 Reduced 75.63%
231,540 $22.2 Million
Q3 2020

Nov 13, 2020
BUY
$96.16 - $135.15 $3.61 Million - $5.07 Million
37,532 Added 4.11%
950,141 $91.4 Million
Q2 2020

Aug 11, 2020
BUY
$85.09 - $130.36 $57.6 Million - $88.3 Million
677,365 Added 287.94%
912,609 $111 Million
Q1 2020

May 15, 2020
BUY
$75.11 - $113.76 $22,382 - $33,900
298 Added 0.13%
235,244 $20.4 Million
Q4 2019

Feb 14, 2020
BUY
$86.8 - $118.57 $46,524 - $63,553
536 Added 0.23%
234,946 $25.3 Million
Q3 2019

Nov 14, 2019
SELL
$83.82 - $101.5 $609,539 - $738,108
-7,272 Reduced 3.01%
234,410 $21.1 Million
Q2 2019

Aug 14, 2019
BUY
$72.24 - $91.27 $598,002 - $755,533
8,278 Added 3.55%
241,682 $20.4 Million
Q1 2019

May 15, 2019
SELL
$69.31 - $91.53 $2.68 Million - $3.55 Million
-38,731 Reduced 14.23%
233,404 $20.6 Million
Q4 2018

Feb 15, 2019
SELL
$68.32 - $124.36 $31 Million - $56.4 Million
-453,627 Reduced 62.5%
272,135 $19.4 Million
Q3 2018

Nov 15, 2018
SELL
$98.88 - $125.85 $10.7 Million - $13.6 Million
-108,387 Reduced 12.99%
725,762 $89.2 Million
Q2 2018

Aug 14, 2018
BUY
$75.3 - $105.99 $4.74 Million - $6.68 Million
62,979 Added 8.17%
834,149 $81.9 Million
Q1 2018

May 11, 2018
BUY
$75.88 - $92.43 $4.65 Million - $5.66 Million
61,249 Added 8.63%
771,170 $64 Million
Q4 2017

Feb 15, 2018
SELL
$58.53 - $77.59 $3.12 Million - $4.14 Million
-53,311 Reduced 6.98%
709,921 $55.1 Million
Q3 2017

Nov 08, 2017
BUY
$47.97 - $61.28 $36.6 Million - $46.8 Million
763,232
763,232 $46.8 Million

Others Institutions Holding NBIX

# of Institutions
725
Shares Held
102M
Call Options Held
230K
Put Options Held
477K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.9B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email